4-150852337-G-C
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001364905.1(LRBA):c.3373C>G(p.Leu1125Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000613 in 1,613,932 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. L1125L) has been classified as Likely benign.
Frequency
Consequence
NM_001364905.1 missense
Scores
Clinical Significance
Conservation
Publications
- combined immunodeficiency due to LRBA deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001364905.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LRBA | NM_001364905.1 | MANE Select | c.3373C>G | p.Leu1125Val | missense | Exon 23 of 57 | NP_001351834.1 | ||
| LRBA | NM_001440430.1 | c.3373C>G | p.Leu1125Val | missense | Exon 23 of 58 | NP_001427359.1 | |||
| LRBA | NM_006726.5 | c.3373C>G | p.Leu1125Val | missense | Exon 23 of 58 | NP_006717.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LRBA | ENST00000651943.2 | MANE Select | c.3373C>G | p.Leu1125Val | missense | Exon 23 of 57 | ENSP00000498582.2 | ||
| LRBA | ENST00000357115.9 | TSL:1 | c.3373C>G | p.Leu1125Val | missense | Exon 23 of 58 | ENSP00000349629.3 | ||
| LRBA | ENST00000510413.5 | TSL:1 | c.3373C>G | p.Leu1125Val | missense | Exon 23 of 57 | ENSP00000421552.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152206Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 251196 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000623 AC: 91AN: 1461608Hom.: 0 Cov.: 32 AF XY: 0.0000605 AC XY: 44AN XY: 727134 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152324Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74480 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Combined immunodeficiency due to LRBA deficiency Uncertain:1
This sequence change replaces leucine with valine at codon 1125 of the LRBA protein (p.Leu1125Val). The leucine residue is weakly conserved and there is a small physicochemical difference between leucine and valine. This variant is present in population databases (rs138238756, ExAC 0.009%). This variant has not been reported in the literature in individuals affected with LRBA-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Inborn genetic diseases Uncertain:1
The c.3373C>G (p.L1125V) alteration is located in exon 23 (coding exon 22) of the LRBA gene. This alteration results from a C to G substitution at nucleotide position 3373, causing the leucine (L) at amino acid position 1125 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
not provided Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at